Executive Vice President, Life Sciences Business Unit
Adam Taich is the Executive Vice President of the Life Sciences Business Unit at SomaLogic. He has over 20 years of experience in the life sciences and healthcare markets. His career has spanned a diverse set of roles, including general management, commercial, finance and corporate development.
Prior to joining SomaLogic, Mr. Taich served as the Vice President and General Manager of the molecular biology business of Thermo Fisher. In this role, he was instrumental in standing up the company’s response to supply critical raw materials for COVID-19 diagnostics and vaccines. While at Thermo Fisher, he also led the protein and cell analysis business, strategy and corporate development for the life sciences group, global service and support (field service engineering, field application scientists, technical support, customer care and sales) and a variety of finance leadership roles earlier in his career. He joined Thermo Fisher via their acquisition of Life Technologies, which was formed through a merger involving Invitrogen a few years after he joined in 2004.
Mr. Taich received his Bachelor of Arts from Miami University in Oxford, Ohio.